Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 | 2021 | 2475 | 0.960 |
Why?
|
| Oxazoles | 4 | 2010 | 61 | 0.860 |
Why?
|
| Apoptosis | 8 | 2021 | 7763 | 0.700 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2021 | 126 | 0.700 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 174 | 0.680 |
Why?
|
| Thiazoles | 4 | 2010 | 723 | 0.640 |
Why?
|
| Organic Cation Transport Proteins | 4 | 2002 | 25 | 0.590 |
Why?
|
| Harringtonines | 2 | 2010 | 93 | 0.420 |
Why?
|
| RNA, Neoplasm | 3 | 2010 | 806 | 0.400 |
Why?
|
| Piperidines | 4 | 2021 | 1087 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2011 | 1544 | 0.390 |
Why?
|
| Flavonoids | 3 | 2009 | 201 | 0.370 |
Why?
|
| RNA Polymerase II | 2 | 2009 | 184 | 0.370 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2010 | 320 | 0.370 |
Why?
|
| Nucleosides | 2 | 2000 | 63 | 0.340 |
Why?
|
| Carrier Proteins | 4 | 2002 | 2101 | 0.330 |
Why?
|
| Kidney | 4 | 2002 | 2124 | 0.320 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 5 | 2011 | 288 | 0.310 |
Why?
|
| Organic Cation Transporter 1 | 3 | 2002 | 4 | 0.300 |
Why?
|
| Tubercidin | 3 | 2002 | 6 | 0.300 |
Why?
|
| Drug Synergism | 4 | 2021 | 1360 | 0.290 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2021 | 4961 | 0.280 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 894 | 0.260 |
Why?
|
| Membrane Proteins | 3 | 2002 | 2927 | 0.260 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2010 | 749 | 0.240 |
Why?
|
| Transcription, Genetic | 3 | 2011 | 3345 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2011 | 5407 | 0.200 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2014 | 1350 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 5762 | 0.160 |
Why?
|
| Lymphocytes | 3 | 2010 | 1275 | 0.160 |
Why?
|
| Deoxycytidine | 2 | 2014 | 1390 | 0.160 |
Why?
|
| Organic Cation Transporter 2 | 4 | 2002 | 5 | 0.150 |
Why?
|
| Adenine | 1 | 2021 | 668 | 0.150 |
Why?
|
| Stromal Cells | 2 | 2010 | 827 | 0.130 |
Why?
|
| Xenopus laevis | 3 | 2002 | 271 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2009 | 895 | 0.130 |
Why?
|
| Cell Death | 2 | 2010 | 687 | 0.130 |
Why?
|
| Transfection | 3 | 2010 | 3119 | 0.120 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 2634 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 3617 | 0.120 |
Why?
|
| Oocytes | 3 | 2002 | 418 | 0.110 |
Why?
|
| Biological Transport | 3 | 2014 | 632 | 0.110 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2011 | 124 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 3 | 2014 | 5249 | 0.100 |
Why?
|
| Ion Transport | 2 | 2002 | 69 | 0.100 |
Why?
|
| Phenanthrenes | 1 | 2011 | 43 | 0.100 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 90 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 31000 | 0.100 |
Why?
|
| Benzoquinones | 1 | 2011 | 110 | 0.100 |
Why?
|
| Mitochondrial Membranes | 1 | 2010 | 59 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 662 | 0.090 |
Why?
|
| RNA, Small Nuclear | 1 | 2010 | 57 | 0.090 |
Why?
|
| Endonucleases | 1 | 2011 | 184 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 189 | 0.090 |
Why?
|
| Tetraethylammonium | 2 | 2000 | 16 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2021 | 12105 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 337 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2010 | 66 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2009 | 4950 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 128 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2010 | 252 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 16645 | 0.080 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 704 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2010 | 6417 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 591 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2011 | 607 | 0.080 |
Why?
|
| Humans | 17 | 2021 | 270903 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2010 | 3596 | 0.070 |
Why?
|
| Purines | 1 | 2009 | 271 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2011 | 903 | 0.070 |
Why?
|
| Cell Survival | 3 | 2011 | 3064 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2007 | 318 | 0.070 |
Why?
|
| Cell Communication | 1 | 2009 | 517 | 0.070 |
Why?
|
| Aged | 5 | 2021 | 73259 | 0.070 |
Why?
|
| Caspases | 1 | 2009 | 679 | 0.070 |
Why?
|
| Vidarabine | 1 | 2011 | 1383 | 0.070 |
Why?
|
| K562 Cells | 1 | 2006 | 345 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 969 | 0.060 |
Why?
|
| Middle Aged | 5 | 2021 | 90230 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 2347 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2010 | 2142 | 0.060 |
Why?
|
| Adult | 3 | 2021 | 81883 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2005 | 316 | 0.060 |
Why?
|
| DNA Adducts | 2 | 2014 | 214 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2011 | 14808 | 0.050 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 1824 | 0.050 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1964 | 0.050 |
Why?
|
| Imatinib Mesylate | 1 | 2006 | 1690 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1472 | 0.050 |
Why?
|
| Benzamides | 1 | 2006 | 1879 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2006 | 1144 | 0.050 |
Why?
|
| Cytarabine | 1 | 2007 | 2014 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2014 | 931 | 0.050 |
Why?
|
| Azacitidine | 1 | 2007 | 1219 | 0.050 |
Why?
|
| RNA | 1 | 2005 | 1065 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2091 | 0.040 |
Why?
|
| Male | 5 | 2021 | 128438 | 0.040 |
Why?
|
| LLC-PK1 Cells | 1 | 1999 | 7 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 1431 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 2281 | 0.040 |
Why?
|
| Female | 5 | 2021 | 148813 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 5020 | 0.040 |
Why?
|
| Animals | 7 | 2011 | 62190 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2010 | 7250 | 0.040 |
Why?
|
| Cell Line | 2 | 2011 | 5344 | 0.040 |
Why?
|
| Piperazines | 1 | 2006 | 2144 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 939 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 3029 | 0.040 |
Why?
|
| Mice | 5 | 2011 | 35624 | 0.030 |
Why?
|
| Cystatins | 1 | 1996 | 18 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1996 | 94 | 0.030 |
Why?
|
| Insecticides | 1 | 1996 | 48 | 0.030 |
Why?
|
| Plant Proteins | 1 | 1996 | 133 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 90 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1999 | 1165 | 0.030 |
Why?
|
| Swine | 1 | 1999 | 1608 | 0.030 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Rats | 2 | 2000 | 6556 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2014 | 131 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2006 | 3662 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 591 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 3350 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2002 | 5719 | 0.030 |
Why?
|
| Tumor Microenvironment | 2 | 2014 | 3022 | 0.020 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 14628 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 7262 | 0.020 |
Why?
|
| Time Factors | 1 | 2005 | 13023 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 213 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 319 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 196 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 787 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2014 | 696 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 428 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 900 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 827 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2011 | 582 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 600 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 632 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2007 | 75 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 1830 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 1030 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2010 | 1322 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 2198 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 3202 | 0.020 |
Why?
|
| Pyridines | 1 | 2011 | 1310 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6258 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2011 | 2441 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 1459 | 0.010 |
Why?
|
| DNA Repair | 1 | 2011 | 1911 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 1986 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 3070 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3907 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 5080 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 5718 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1999 | 9 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 3669 | 0.010 |
Why?
|
| Deoxyadenosines | 1 | 1999 | 43 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 13377 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1999 | 383 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 7383 | 0.010 |
Why?
|
| Vinblastine | 1 | 1999 | 462 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1999 | 314 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 7784 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 9469 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2007 | 2760 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12515 | 0.010 |
Why?
|
| Papain | 1 | 1996 | 7 | 0.010 |
Why?
|
| Oryza | 1 | 1996 | 34 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 22495 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 2221 | 0.010 |
Why?
|
| Plasmids | 1 | 1996 | 936 | 0.010 |
Why?
|
| Cisplatin | 1 | 1999 | 2499 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 15904 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 10702 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1996 | 1306 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 33709 | 0.000 |
Why?
|